Softing AG (SYT) | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Home
Companies
Softing AG

BRIEF

published on 11/12/2024 at 08:35, 9 days 1 hour ago

Softing AG Reports Decline in Revenue Amidst Economic Challenges

Economic Challenges Earnings Decline 2024 Financial Outlook Softing AG Automotive Segment Growth
PRESS RELEASE

published on 11/12/2024 at 08:30, 9 days 2 hours ago

Interim Statement on the 3rd Quarter and First 9 Months of 2024
Softing AG reports a 20% decrease in revenue in the first 9 months of 2024 due to global economic weakness. Key markets impacted include mechanical engineering and IT infrastructure

Revenue Decrease IT Infrastructure Global Economy Softing AG Mechanical Engineering
BRIEF

published on 09/25/2024 at 11:31, 1 month 25 days ago

Softing AG Announces Cash Capital Increase with Exclusion of Subscription Rights

Frankfurt Stock Exchange Capital Increase New Shares Growth Financing Softing AG
PRESS RELEASE

published on 09/25/2024 at 11:26, 1 month 25 days ago

EQS-Adhoc: Softing AG Resolves Cash Capital Increase from Authorized Capital with Exclusion of Subscription Rights
Softing AG resolves cash capital increase from authorized capital, excluding subscription rights, to finance further growth. New shares offered to investor at EUR 4.60 each

Capital Increase Authorized Capital Growth Subscription Rights Softing AG
BRIEF

published on 05/07/2024 at 07:35, 6 months 14 days ago

Softing AG Reports on First Quarter of 2024 Amid Economic Challenges

2024 Financial Performance Market Penetration Softing AG Economic Challenge Quarterly Revenue Growth
PRESS RELEASE

published on 05/07/2024 at 07:30, 6 months 14 days ago

Softing AG: Interim Statement on the 1st Quarter of 2024
Softing AG reports on the 1st Quarter of 2024, highlighting revenue, orders, and EBIT. Despite economic challenges, the company remains optimistic for the year ahead

Revenue EBIT Orders 1st Quarter 2024 Softing AG
PRESS RELEASE

published on 08/09/2023 at 13:00, 1 year 3 months ago

EQS-Adhoc: Softing AG: Earnings Guidance Raised
PRESS RELEASE

published on 05/03/2023 at 07:44, 1 year 6 months ago

Softing AG: Interim Statement on the 1st Quarter of 2023
PRESS RELEASE

published on 04/18/2023 at 16:56, 1 year 7 months ago

EQS-Adhoc: Softing AG: Results in the first quarter of 2023 clearly exceeds expectations

Accesswire

Published on 11/21/2024 at 10:03, 28 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 31 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 31 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 56 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 6 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 26 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 29 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 31 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 31 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 30 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 33 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 11 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 46 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 46 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE